Suppr超能文献

肿瘤周围浸润免疫细胞对肝癌患者生存的影响。

Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma.

机构信息

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

出版信息

Cancer Sci. 2022 Dec;113(12):4048-4058. doi: 10.1111/cas.15437. Epub 2022 Oct 5.

Abstract

Inflammatory and immune cells in the tumor microenvironment are reported to be associated with tumor progression in several cancers. In total, 225 patients who underwent initial and curative hepatectomy for hepatocellular carcinoma (HCC) from 2004 to 2013 were enrolled in this study. Tumor-associated neutrophils (TANs), M2 macrophages (TAMs; tumor-associated macrophages), CD8 T cells, and regulatory T cells (Tregs) were evaluated by immunohistochemistry (IHC), and their relationships with patient clinicopathological characteristics and prognosis were evaluated. IHC was performed focusing on TANs first. We could not find a relationship between intratumoral and peritumoral TANs and clinicopathological features except for the fibrous capsule and infiltration of tumors into capsule. Next, TAMs, CD8 cells and Tregs were evaluated by IHC. At the peritumoral area, TANs and TAMs (r = 0.36, p = 0.001) or Tregs (r = 0.16, p = 0.008) showed a positive correlation, whereas TANs and CD8 cells showed a negative correlation (r = -0.16, p = 0.02). As for survival outcomes, at the peritumoral area, high TANs (p = 0.0398), low CD8 cells (p = 0.0275), and high TAMs (p = 0.001) were significantly associated with worse overall survival (OS). In addition, high TANs (p = 0.010), and high TAMs (p = 0.00125) were significantly associated with worse disease-free survival (DFS). Finally, we established a risk signature model by combining the expression patterns of these cells. The high-risk signature group had significantly worse OS (p = 0.0277) and DFS (p = 0.0219) compared with those in the low-risk signature group. Our risk signature based on immune cells at the peritumoral area of the HCC can predict patient prognosis of HCC after curative hepatectomy.

摘要

肿瘤微环境中的炎症和免疫细胞被报道与几种癌症的肿瘤进展有关。本研究共纳入 2004 年至 2013 年间接受根治性肝切除术治疗肝细胞癌(HCC)的 225 例患者。通过免疫组织化学(IHC)评估肿瘤相关中性粒细胞(TANs)、M2 巨噬细胞(TAMs;肿瘤相关巨噬细胞)、CD8 T 细胞和调节性 T 细胞(Tregs),并评估它们与患者临床病理特征和预后的关系。IHC 首先针对 TANs 进行。除了纤维囊和肿瘤浸润包膜外,我们未发现肿瘤内和肿瘤周围 TANs 与临床病理特征之间的关系。接下来,通过 IHC 评估 TAMs、CD8 细胞和 Tregs。在肿瘤周围区域,TANs 和 TAMs(r=0.36,p=0.001)或 Tregs(r=0.16,p=0.008)呈正相关,而 TANs 和 CD8 细胞呈负相关(r=-0.16,p=0.02)。就生存结果而言,在肿瘤周围区域,高 TANs(p=0.0398)、低 CD8 细胞(p=0.0275)和高 TAMs(p=0.001)与总生存期(OS)更差显著相关。此外,高 TANs(p=0.010)和高 TAMs(p=0.00125)与无病生存期(DFS)更差显著相关。最后,我们通过组合这些细胞的表达模式建立了一个风险特征模型。高危特征组的 OS(p=0.0277)和 DFS(p=0.0219)显著差于低危特征组。我们基于 HCC 肿瘤周围区域免疫细胞的风险特征模型可以预测 HCC 根治性肝切除术后患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b6/9746053/a3c43242ada9/CAS-113-4048-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验